| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ANAPTYSBIO, INC | Director | Common Stock | 11.9K | $238K | $20.03 | 15 Jun 2025 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 0 | $92.3K | $15.30 | 15 Jun 2025 | Direct |
| ANAPTYSBIO, INC | Director | Restricted Stock Unit | 0 | $0 | $23.72 | 15 Jun 2024 | Direct |
| ANAPTYSBIO, INC | Director | Stock Option (right to buy) | 16.5K | 07 Jan 2025 | Direct | ||
| Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 16.5K | 05 Jun 2025 | Direct | ||
| Celldex Therapeutics, Inc. | Director | Non-Qualified Stock Option (right to buy) | 16.5K | 13 Jun 2024 | Direct | ||
| Avalo Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 1.57K | 30 Sep 2025 | Direct | ||
| ChemoCentryx, Inc. | EVP, Chief Medical Officer, Director | Common Stock | 0 | $50.95 | 20 Oct 2022 | Direct | |
| ChemoCentryx, Inc. | EVP, Chief Medical Officer, Director | Restricted Stock Unit | 0 | 20 Oct 2022 | Direct | ||
| ChemoCentryx, Inc. | EVP, Chief Medical Officer, Director | Stock Option | 0 | 20 Oct 2022 | Direct | ||
| Provention Bio, Inc. | Director | Option to Purchase Common Stock | 0 | 27 Apr 2023 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| AVTX | Avalo Therapeutics, Inc. | 30 Sep 2025 | 1 | $0 | 4 | Director | 02 Oct 2025, 16:11 |
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 1 | $0 | 4 | Director | 18 Jun 2025, 16:08 |
| AVTX | Avalo Therapeutics, Inc. | 17 Jun 2025 | 0 | $0 | 3 | Director | 18 Jun 2025, 16:00 |
| ANAB | ANAPTYSBIO, INC | 15 Jun 2025 | 3 | $0 | 4 | Director | 17 Jun 2025, 18:33 |
| CLDX | Celldex Therapeutics, Inc. | 05 Jun 2025 | 1 | $0 | 4 | Director | 09 Jun 2025, 16:10 |
| ANAB | ANAPTYSBIO, INC | 07 Jan 2025 | 2 | $0 | 4 | Director | 07 Jan 2025, 17:30 |
| ANAB | ANAPTYSBIO, INC | 15 Jun 2024 | 3 | $0 | 4 | Director | 18 Jun 2024, 20:14 |
| CLDX | Celldex Therapeutics, Inc. | 13 Jun 2024 | 1 | $0 | 4 | Director | 17 Jun 2024, 16:11 |
| ANAB | ANAPTYSBIO, INC | 03 Jan 2024 | 2 | $0 | 4 | Director | 05 Jan 2024, 17:01 |
| PRVB | Provention Bio, Inc. | 27 Apr 2023 | 1 | $0 | 4 | Director | 27 Apr 2023, 18:03 |
| ANAB | ANAPTYSBIO, INC | 03 Apr 2023 | 4 | $0 | 4 | Director | 06 Apr 2023, 17:05 |
| ANAB | ANAPTYSBIO, INC | 03 Apr 2023 | 0 | $0 | 3 | Director | 06 Apr 2023, 17:03 |
| CLDX | Celldex Therapeutics, Inc. | 16 Feb 2023 | 1 | $0 | 4 | Director | 21 Feb 2023, 15:30 |
| CLDX | Celldex Therapeutics, Inc. | 16 Feb 2023 | 0 | $0 | 3 | Director | 21 Feb 2023, 15:20 |
| PRVB | Provention Bio, Inc. | 03 Jan 2023 | 1 | $0 | 4 | Director | 05 Jan 2023, 15:31 |
| PRVB | Provention Bio, Inc. | 03 Jan 2023 | 0 | $0 | 3 | Director | 05 Jan 2023, 15:29 |
| CCXI | ChemoCentryx, Inc. | 20 Oct 2022 | 8 | $0 | 4 | EVP, Chief Medical Officer, Director | 24 Oct 2022, 19:13 |
| CCXI | ChemoCentryx, Inc. | 20 May 2022 | 2 | $0 | 4 | EVP, Chief Medical Officer, Director | 24 May 2022, 19:27 |
| CCXI | ChemoCentryx, Inc. | 27 Mar 2022 | 2 | $0 | 4 | EVP, Chief Medical Officer, Director | 29 Mar 2022, 19:50 |
| CCXI | ChemoCentryx, Inc. | 22 Feb 2022 | 2 | $0 | 4 | EVP, Chief Medical Officer, Director | 24 Feb 2022, 19:46 |
| CCXI | ChemoCentryx, Inc. | 05 Oct 2021 | 1 | $0 | 4 | EVP, Chief Medical Officer, Director | 07 Oct 2021, 20:52 |
| CCXI | ChemoCentryx, Inc. | 20 May 2021 | 4 | $0 | 4 | Director | 24 May 2021, 19:55 |